Compare Pfizer Inc (PFE) vs Union Pacific Corporation (UNP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Union Pacific Corporation — how do they compare? Pfizer Inc trades at $28.1 (market cap $158.56B), while Union Pacific Corporation trades at $278.26 (market cap $165.27B). The key difference: Pfizer Inc and Union Pacific Corporation are close in size by market cap, and Pfizer Inc pays the higher dividend (6.18%). Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and Union Pacific Corporation for 105 Days on average.
| PFE | UNP | |
|---|---|---|
Market Cap | $158.56B | $165.27B |
Volume | 44,138,282 | 1,474,117 |
Sector | Health | Industrials |
52-Week High | $29.02 | $310.62 |
52-Week Low | $23.67 | $216.37 |
Typical Hold Time | 158 Days | 105 Days |
Enterprise Value | $210.06B | $194.33B |
Dividend Yield | 6.18% | 2.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
Union Pacific (UNP) trades at $274.68, down 0.7% with a bearish technical signal despite strong Q2 2026 earnings beat. The railroad operator maintains robust fundamentals with 28.85% net margin and 39.7% ROE, supported by $9.3B operating cash flow. Recent developments include battery-electric locomotive deployment and progress on the Norfolk Southern combination, while analyst consensus remains bullish with $332.10 price target.
UNP presents a compelling value opportunity with 21% upside to consensus target, though merger uncertainty and fuel cost pressures create near-term volatility. The company's irreplaceable infrastructure and dividend growth streak provide long-term stability, but investors should monitor regulatory approval of the Norfolk Southern deal and operating ratio pressures from rising diesel prices.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Union Pacific Corporation
Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two thirds of the U.S., UP generated roughly $22 billion of revenue in 2021 by hauling coal, industrial products, intermodal containers, agriculture goods, chemicals, and automotive goods. UP owns about one fourth of Mexican railroad Ferromex and derives about 10% of its revenue hauling freight to and from Mexico.
Read more on UNP →
